References
Consigny S, Dhedin N, Datry A, Choquet S, Leblond V, Chosidow O (2003) Successful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient. Clin Infect Dis 37:311–313
Nucci M, Anaissie E (2002) Cutaneous infection by Fusarium species in healthy and immunocompromised host: implications for diagnosis and management. Clin Infect Dis 35:909–920
Nucci M, Anaissie EJ, Queiroz-Telles et al (2003) Outcome predictor of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315–319
Ortoneda M, Capilla J, Pastor FJ, Pujol I, Guarro J (2002) Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis. Antimicrob Agents Chemother 46:2273–2275
Pujol I, Guarro J, Gene J, Sala J (1997) In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother 39:163–167
Walsh TJ, Goodman JL, Pappas P et al (2001) Safety, tolerance and pharmacokinetics of high-dose liposomal amphotericin B (Ambisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother 45:3487–3496
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cudillo, L., Tendas, A., Picardi, A. et al. Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia. Ann Hematol 85, 136–138 (2006). https://doi.org/10.1007/s00277-005-0002-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-005-0002-3